NCT06735820
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06735820
Title Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST (MEKMDM2)
Acronym MEKMDM2
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AeRang Kim
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.